Parrella A, Braunack-Mayer A, Gold M, Marshall H, Baghurst P. Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study. BMC Health Serv Res. 2013; 13:313. doi: 10.1186/1472-6963-13-313.
Gahunia J, Bigham M, Konrad S, Snow ME. Adverse events following immunization: evaluating an enhanced nursing role for PHNs. Can Nurse. 2013; 109(2):16-20.
Rubin KM, Vona K, Madden K, McGettigan S, Braun IM. Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurse's perspective. Support Care Cancer. 2012; 20(8):1601-11.
Rubin KM. Managing immune-related adverse events to ipilimumab: a nurse's guide. Clin J Oncol Nurs. 2012; 16(2):E69-75.
Nelson R. Childhood vaccinations. Am J Nurs. 2011; 111(11):19-20.
Lang DS, Hagger C, Pearson A. Safety of rapid rituximab infusion in adult cancer patients: a systematic review. Int J Nurs Pract. 2011; 17(4):357-69.
Marentette T, El-Masri MM. Predicting seasonal influenza vaccination among hospital-based nurses. Clin Nurs Res. 2011; 20(4):422-38.
Dodd MJ, Cho MH, Cooper BA, Petersen J, Bank KA, Lee KA, Miaskowski C. Identification of latent classes in patients who are receiving biotherapy based on symptom experience and its effect on functional status and quality of life. Oncol Nurs Forum. 2011; 38(1):33-42.
Howland RH. Potential adverse effects of discontinuing psychotropic drugs: part 2: antidepressant drugs. J Psychosoc Nurs Ment Health Serv. 2010; 48(7):9-12.
Floyd S. Administering the influenza vaccine. Nurs N Z. 2010; 16(4):20-1.
Ouwerkerk J, Boers-Doets C. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer. Eur J Oncol Nurs. 2010; 14(4):337-49.
Baggott C, Dodd M, Kennedy C, Marina N, Miaskowski C. Multiple symptoms in pediatric oncology patients: a systematic review. J Pediatr Oncol Nurs. 2009; 26(6):325-39.
Michael M, Helm E, Van Graafeiland B, Malinoski F, Bauman J. Influenza vaccination with a live attenuated vaccine. Am J Nurs. 2009; 109(10):44-8.
Giezeman KM, Nauta J, de Bruijn IA, Palache AM. Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity. Vaccine. 2009; 27(18):2414-7.
Dudley-Brown S, Nag A, Cullinan C, Ayers M, Hass S, Panjabi S. Health-related quality-of-life evaluation of crohn disease patients after receiving natalizumab therapy. Gastroenterol Nurs. 2009; 32(5):327-39.
Van Gerpen R. Chemotherapy and biotherapy-induced hypersensitivity reactions. J Infus Nurs. 2009; 32(3):157-65.
Sharts-Hopko NC. Issues in pediatric immunization. MCN Am J Matern Child Nurs. 2009; 34(2):80-8.
Girouard N, Théorêt G. Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis. Can J Neurosci Nurs. 2008;30(4):18-25.
Warren B. Using paracetamol before immunisation--does it work? Nurs N Z. 2007; 13(5):24-5.